OCGN Ocugen new Covid-19 Vaccine and Price Target

NASDAQ:OCGN   Ocugen, Inc
OCGN Ocugen partnered with Bharat Biotech for Covaxin, the first COVID vaccine developed in India to receive emergency authorization.

With the COVID significant rise in cases, hospitalizations and deaths over the last two weeks, vaccines producers are rising once again.

My short term Price Target is 10.30usd